Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception

Author： Hutcheson D.M.   Sanchez-Blazquez P.   Rodriguez-Diaz M.   Garzon J.   Schmidhammer H.   Borsodi A.   Roques B.P.   Maldonado R.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.383, Iss.1, 1999-10, pp. : 29-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sensible use of antisense: how to use oligonucleotides as research tools

By Myers K.J.K.J.   Dean N.M.N.M.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 1, 2000-01 ,pp. : 19-23

Elsevier

Access to resources Recommend Favorite

Cellular delivery of antisense oligonucleotides

By Lebedeva I.   Benimetskaya L.   Stein C.A.   Vilenchik M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 101-119

Elsevier

Access to resources Recommend Favorite

Antisense oligonucleotides as emerging drugs

By Nyce J.W.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

Antisense Oligonucleotides As Therapeutic Agents

By Alama A.   Barbieri F.   Cagnoli M.   Schettini G.  

Pharmacological Research, Vol. 36, Iss. 3, 1997-09 ,pp. : 171-178

Academic Press

Access to resources Recommend Favorite

Antisense Oligonucleotides: The State of the Art#

By  

Current Medicinal Chemistry, Vol. 12, Iss. 19, 2005-09 ,pp. : 2193-2214

Bentham Science Publishers

Access to resources Recommend Favorite